because it needs a spark of ingenuity and it can buy TSLA for lunch money.. AAPL should forget BEATS and buy the most innovative company on Earth.
for the next 12 months.
of an over-priced drug with a shaky patent.
with the other half being owned by Astellas. Its major competitor drug Zytiga is priced lower and is coming off patent very soon. The National Institute of Health questions the exclusivity of MDVN's only drug since it was developed by a university with public money.and the advanced version of this drug has also been sold to JNJ.
12 members of congress want MDVN to explain its outrageous price.